Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1

被引:281
作者
Moore, PL
Crooks, ET
Porter, L
Zhu, P
Cayanan, CS
Grise, H
Corcoran, P
Zwick, MB
Franti, M
Morris, L
Roux, KH
Burton, DR
Binley, JM
机构
[1] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA
[2] Natl Inst Communicable Dis, Johannesburg, South Africa
[3] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA
[4] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA
[5] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[6] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[7] Progen Pharmaceut Inc, Tarrytown, NY 10591 USA
关键词
D O I
10.1128/JVI.80.5.2515-2528.2006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus type I (HIV-1) neutralizing antibodies are thought be distinguished from nonneutralizing antibodies by their ability to recognize functional gp120/gp41 envelope glycoprotein (Env) trimers. The antibody responses induced by natural HIV-1 infection or by vaccine candidates tested to date consist largely of nonneutralizing antibodies. One might have expected a more vigorous neutralizing response, particularly against virus particles that bear functional trimers. The recent surprising observation that nonneutralizing antibodies can specifically capture HIV-1 may provide a clue relating to this paradox. Specifically, it was suggested that forms of Env, to which nonneutralizing antibodies can bind, exist on virus surfaces. Here, we present evidence that HIV-1 particles bear nonfunctional gp120/gp41 monomers and gp120-depleted gp41 stumps. Using a native electrophoresis band shift assay, we show that antibody-trimer binding predicts neutralization and that the nonfunctional forms of Env may account for virus capture by nonneutralizing antibodies. We hypothesize that these nonfunctional forms of Env on particle surfaces serve to divert the antibody response, helping the virus to evade neutralization.
引用
收藏
页码:2515 / 2528
页数:14
相关论文
共 74 条
  • [61] Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein
    Schülke, N
    Vesanen, MS
    Sanders, RW
    Zhu, P
    Lu, M
    Anselma, DJ
    Villa, AR
    Parren, PWHI
    Binley, JM
    Roux, KH
    Maddon, PJ
    Moore, JP
    Olson, WC
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (15) : 7760 - 7776
  • [62] Alternative conformations of HIV-1V3 loops mimic β hairpins in chemokines, suggesting a mechanism for coreceptor selectivity
    Sharon, M
    Kessler, N
    Levy, R
    Zolla-Pazner, S
    Görlach, M
    Anglister, J
    [J]. STRUCTURE, 2003, 11 (02) : 225 - 236
  • [63] Follicular dendritic cells and the persistence of HIV infectivity:: The role of antibodies and Fcγ receptors
    Smith-Franklin, BA
    Keele, BF
    Tew, JG
    Gartner, S
    Szakal, AK
    Estes, JD
    Thacker, TC
    Burton, GF
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (05) : 2408 - 2414
  • [64] IDENTIFICATION AND CHARACTERIZATION OF CONSERVED AND VARIABLE REGIONS IN THE ENVELOPE GENE OF HTLV-III LAV, THE RETROVIRUS OF AIDS
    STARCICH, BR
    HAHN, BH
    SHAW, GM
    MCNEELY, PD
    MODROW, S
    WOLF, H
    PARKS, ES
    PARKS, WP
    JOSEPHS, SF
    GALLO, RC
    WONGSTAAL, F
    [J]. CELL, 1986, 45 (05) : 637 - 648
  • [65] CROSS-CLADE NEUTRALIZATION OF PRIMARY ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY HUMAN MONOCLONAL-ANTIBODIES AND TETRAMERIC CD4-IGG
    TRKOLA, A
    POMALES, AB
    YUAN, H
    KORBER, B
    MADDON, PJ
    ALLAWAY, GP
    KATINGER, H
    BARBAS, CF
    BURTON, DR
    HO, DD
    MOORE, JP
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (11) : 6609 - 6617
  • [66] Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage
    Trkola, A
    Ketas, T
    Kewalramani, VN
    Endorf, F
    Binley, JM
    Katinger, H
    Robinson, J
    Littman, DR
    Moore, JP
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (03) : 1876 - 1885
  • [67] Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1
    Trkola, A
    Purtscher, M
    Muster, T
    Ballaun, C
    Buchacher, A
    Sullivan, N
    Srinivasan, K
    Sodroski, J
    Moore, JP
    Katinger, H
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (02) : 1100 - 1108
  • [68] Immunogenicity and safety of a combined hepatitis A and B vaccine administered concomitantly with either a measles-mumps-rubella or a diphtheria-tetanus-acellular pertussis-inactivated poliomyelitis vaccine mixed with a Haemophilus influenzae type b conjugate vaccine in infants aged 12-18 months
    Usonis, V
    Meriste, S
    Bakasenas, V
    Lutsar, I
    Collard, F
    Stoffeld, A
    Tornieporth, N
    [J]. VACCINE, 2005, 23 (20) : 2602 - 2606
  • [69] Antibody neutralization and escape by HIV-1
    Wei, XP
    Decker, JM
    Wang, SY
    Hui, HX
    Kappes, JC
    Wu, XY
    Salazar-Gonzalez, JF
    Salazar, MG
    Kilby, JM
    Saag, MS
    Komarova, NL
    Nowak, MA
    Hahn, BH
    Kwong, PD
    Shaw, GM
    [J]. NATURE, 2003, 422 (6929) : 307 - 312
  • [70] INCREASE IN SOLUBLE CD4 BINDING TO AND CD4-INDUCED DISSOCIATION OF GP120 FROM VIRIONS CORRELATES WITH INFECTIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    WILLEY, RL
    MARTIN, MA
    PEDEN, KWC
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (02) : 1029 - 1039